Home › Therapeutic areas › Immunology › Systemic Sclerosis
Systemic Sclerosis (13 companies)
Companies with an active program in Systemic Sclerosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACET | Adicet Bio | ImmunologyNeurology+2 Rare | 1 | Phase 1 | 8 |
| ALLO | Allogene Therapeutics | ImmunologyOncology Rare | 1 | Phase 2 | 10 |
| ARTV | Artiva Biotherapeutics | DermatologyImmunology+2 Rare | 1 | Phase 2 | 14 |
| CABA | Cabaletta Bio | DermatologyImmunology+2 Rare | 2 | Phase 2 | 8 |
| IPSC | Century Therapeutics | ImmunologyMetabolic+1 Rare | 2 | Phase 1 | 9 |
| CMMB | Chemomab Therapeutics | GI/HepatologyImmunology+1 Rare | 1 | Phase 2 | 4 |
| FATE | Fate Therapeutics | ImmunologyOncology+1 Rare | 1 | Phase 2 | 10 |
| LQDA | Liquidia | CardiovascularImmunology+1 Rare | 1 | Approved | 10 |
| NKTX | Nkarta | ImmunologyNeurology+1 Rare | 1 | Phase 1 | 8 |
| QNRX | Quoin Pharmaceuticals | DermatologyImmunology Rare | 1 | Phase 2 | 4 |
| TLSA | Tiziana Life Sciences | ImmunologyNeurology Rare | 1 | Phase 2 | 5 |
| XNCR | Xencor | ImmunologyNeurology+1 Rare | 1 | Approved | 28 |
| ZURA | Zura Bio | DermatologyImmunology Rare | 1 | Phase 2 | 5 |
No companies match.